Stay up to date

Rivfloza™ (nedosiran) injection logo

Rivfloza™ is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

Actor portrayal

NOW AVAILABLE

Rivfloza™ offers:

  • Once-monthly dosing
  • Self- or caregiver-administered in the comfort of your own homea

aIn children 9 to 11 years of age weighing 110 pounds (50 kilograms) or more, Rivfloza™ may be administered by a health care professional or a caregiver using the pre-filled syringe. In children 9 to 11 years of age weighing less than 110 pounds, Rivfloza™ vials may be administered by a caregiver after proper training, if a health care professional determines that it is appropriate, and with medical follow-up as necessary. Please see Instructions for Use in full Prescribing Information. 

NOW AVAILABLE

Interested in learning more?

Our NovoCare® patient support team can provide more information about Rivfloza™ and how to get started on treatment. Visit NovoCare® today or contact the NovoCare® team at 844-906-5099.

Go to novocare.com

Talk to your health care provider about once-monthly Rivfloza™

Rivfloza™ (nedosiran) injection is a treatment for primary hyperoxaluria type 1 (PH1).

Learn more
Envelope with checkmark icon

Stay in the know

Be among the first to get updates about once-monthly Rivfloza™, including information about our patient support programs, help with the insurance process, and more.

Sign up
Show more Show less

Important Safety Information

What are the possible side effects of RIVFLOZA™?

The most common side effects of Rivfloza™ include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Please click here for Prescribing Information.

Rivfloza™ is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.

If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.

What is RIVFLOZA™?

Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.

What is RIVFLOZA™?

Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.

Show more Show less
Show more Show less

What is RIVFLOZA™?

Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.

What is RIVFLOZA™?

Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.

Important Safety Information

What are the possible side effects of RIVFLOZA™?

The most common side effects of Rivfloza™ include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Please click here for Prescribing Information.

Rivfloza™ is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.

If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.

Important Safety Information

What are the possible side effects of RIVFLOZA™?

The most common side effects of Rivfloza™ include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Please click here for Prescribing Information.

Rivfloza™ is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.

If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.

Important Safety Information

What are the possible side effects of RIVFLOZA™?

The most common side effects of Rivfloza™ include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.

Please click here for Prescribing Information.

Rivfloza™ is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.

If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.

What is RIVFLOZA™?

Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.

What is RIVFLOZA™?

Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.

It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.

Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
Rivfloza™ is a trademark of Novo Nordisk Healthcare AG.
NovoCare® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.

 

© 2024 Novo Nordisk All rights reserved. US24RVZA00019 February 2024

© 2023 Novo Nordisk All rights reserved. US23NED00033 October 2023

You are about to leave Rivfloza.com, a Novo Nordisk website.

Click “Continue” to leave the site and come back to visit us another time. Click “Return to site” to stay and learn more about Rivfloza™ (nedosiran) injection.

Continue

You are about to leave Rivfloza.com, a Novo Nordisk website.

Click “Continue” to leave the site. Novo Nordisk isn’t responsible for the following content. Come back to visit us another time. Click “Return to site” to stay and learn more about Rivfloza™ (nedosiran) injection.

Continue
Access Resources